A detailed history of Poehling Capital Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 1,957 shares of MRK stock, worth $205,152. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,957
Previous 7,336 73.32%
Holding current value
$205,152
Previous $967,000 74.97%
% of portfolio
0.07%
Previous 0.26%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$123.8 - $132.96 $665,920 - $715,191
-5,379 Reduced 73.32%
1,957 $242,000
Q1 2024

May 09, 2024

SELL
$113.24 - $131.95 $2,831 - $3,298
-25 Reduced 0.34%
7,336 $967,000
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $107,392 - $116,869
-1,072 Reduced 12.71%
7,361 $802,000
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $15,854 - $17,606
-154 Reduced 1.79%
8,433 $868,000
Q2 2023

Aug 14, 2023

SELL
$108.61 - $118.38 $15,857 - $17,283
-146 Reduced 1.67%
8,587 $990,000
Q1 2023

May 11, 2023

SELL
$102.94 - $114.86 $408,362 - $455,649
-3,967 Reduced 31.24%
8,733 $929,000
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $490,538 - $628,937
-5,610 Reduced 30.64%
12,700 $1.41 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $2.36 Million - $2.65 Million
-27,928 Reduced 60.4%
18,310 $1.58 Million
Q2 2022

Aug 09, 2022

SELL
$83.49 - $94.64 $117,136 - $132,779
-1,403 Reduced 2.94%
46,238 $4.22 Million
Q1 2022

May 16, 2022

BUY
$73.51 - $82.4 $22,641 - $25,379
308 Added 0.65%
47,641 $3.91 Million
Q4 2021

Jan 10, 2022

BUY
$72.28 - $90.54 $43,512 - $54,505
602 Added 1.29%
47,333 $3.63 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $120,494 - $132,513
1,681 Added 3.73%
46,731 $3.51 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $117,909 - $130,420
1,677 Added 3.87%
45,050 $3.5 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $1.48 Million - $1.75 Million
21,537 Added 98.63%
43,373 $3.34 Million
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $565,834 - $627,960
7,884 Added 56.51%
21,836 $1.79 Million
Q3 2020

Nov 10, 2020

BUY
$73.18 - $82.95 $17,124 - $19,410
234 Added 1.71%
13,952 $1.16 Million
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $7,253 - $8,253
103 Added 0.76%
13,718 $1.06 Million
Q1 2020

May 06, 2020

BUY
$63.36 - $87.82 $618,773 - $857,650
9,766 Added 253.73%
13,615 $1.05 Million
Q2 2019

Aug 09, 2019

SELL
$69.84 - $81.59 $14,107 - $16,481
-202 Reduced 4.99%
3,849 $323,000
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $5,545 - $6,435
85 Added 2.14%
4,051 $310,000
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $175,896 - $206,844
3,049 Added 332.5%
3,966 $281,000
Q2 2018

Aug 08, 2018

SELL
$50.83 - $59.72 $124,381 - $146,134
-2,447 Reduced 72.74%
917 $56,000
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $173,649 - $207,356
3,364
3,364 $189,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $266B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Poehling Capital Management, Inc. Portfolio

Follow Poehling Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Poehling Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Poehling Capital Management, Inc. with notifications on news.